SCHEMBL18092014

SCHEMBL18092014

CCNC(=O)Oc1cnc(/C=C/c2c(-c3ccc(F)cn3)noc2C)s1

nearest known ligand 0.48

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 17/20 0.48
KMT2A Q03164 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18092018 0.91 GABRA5 (0.49) GABRA5
SCHEMBL18092032 0.90 GABRA5 (0.51) GABRA5
SCHEMBL18092044 0.90 GABRA5 (0.42) GABRA5
SCHEMBL18092015 0.89 GABRA5 (0.42) GABRA5
SCHEMBL18092003 0.87 GABRA5 (0.41) GABRA5
SCHEMBL18091975 0.87 GABRA5 (0.44) GABRA5
SCHEMBL18092031 0.86 GABRA5 (0.40) GABRA5KMT2A
SCHEMBL18092025 0.86 GABRA5 (0.39) GABRA5
SCHEMBL286050 0.85 GABRA5 (0.51) GABRA5
SCHEMBL286051 0.85 GABRA5 (0.51) GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2427459-B1 ISOXAZOLE-THIAZOLE DERIVATIVES AS GABA A RECEPTOR INVERSE AGONISTS FOR USE IN THE TREATMENT OF COGNITIVE DISORDERS HOFFMANN LA ROCHE (CH) 2016-09-28 EP claimed